Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The FDA warns that compounded GLP-1s can be risky
Product Specifications The Body Pharm Retatrutide 64mg pen is a multi-dose subcutaneous injection device containing 64mg of lyophilised-then-solubilised retatrutide (LY3437943), a synthetic GIP/GLP-1/glucagon triple receptor agonist developed by Eli Lilly and currently in Phase 3 obesity trials [7][6]
Barley is another good source of beta-glucans, which may stimulate GLP-1 production
If youre taking or considering a GLP-1, dont go it alone
US$ 27.64
US$ 25.19
US$ 23.00
US$ 29.21
